GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual GIP/GLP-1 agonist tirzepatide carry the clinical evidence: STEP for semaglutide ( The New England Journal of Medicine , 2021), SURMOUNT for tirzepatide (NEJM, 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM, 2024)
BPC 157 treatment allowed for injury healing that was sustained over the course of 72 days 1
Fathizadeh H, Milajerdi A, Reiner , Kolahdooz F, Chamani M, Amirani E et al (2019) The effects of l-carnitine supplementation on serum lipids: a systematic review and meta-analysis of randomized controlled trials
When Cooking Isn't Going to Happen Batch-cooking four bowls on a Sunday solves a chunk of the week
Testing: How People Get Diagnosed Users describe a range of testing approaches
When your body processes these hormones at an accelerated rate your birth control method may not work properly which can result in breakthrough bleeding or unexpected pregnancies